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ACUTE RADIATION SYNDROME
Acute Radiation Syndrome (ARS) (sometimes known as radiation 
toxicity or radiation sickness) is an acute illness caused by 
irradiation of the entire body (or most of the body) by a high dose 
of penetrating radiation in a very short period of time (usually a 
matter of minutes). The major cause of this syndrome is depletion 
of immature parenchymal stem cells in specific tissues. Examples of 
people who suffered from ARS are the survivors of the Hiroshima 
and Nagasaki atomic bombs, the firefighters that first responded 
after the Chernobyl Nuclear Power Plant event in 1986, and some 
unintentional exposures to sterilization irradiators.
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THE REQUIRED CONDITIONS FOR 
ACUTE RADIATION SYNDROME (ARS) 
• ARE:The radiation dose must be large (i.e., greater than 0.7 Gray 
(Gy)1, 2 or 70 rads).
 ° Mild symptoms may be observed with doses as low as 0.3 Gy or 
30 rads.
• The dose usually must be external (i.e., the source of radiation is 
outside of the patient’s body).
 ° Radioactive materials deposited inside the body have produced 
some ARS effects only in extremely rare cases.
• The radiation must be penetrating (i.e., able to reach the 
internal organs).
 ° High energy X-rays, gamma rays, and neutrons are penetrating 
radiations.
• The entire body (or a signifi cant portion of it) must have received 
the dose3.
 ° Most radiation injuries are local, frequently involving the 
hands, and these local injuries seldom cause classical signs 
of ARS.
• The dose must have been delivered in a short time (usually a 
matter of minutes).
 ° Fractionated doses are often used in radiation therapy. These 
large total doses are delivered in small daily amounts over a 
period of time. Fractionated doses are less effective at inducing 
ARS than a single dose of the same magnitude.
1 The Gray (Gy) is a unit of absorbed dose and refl ects an amount of energy 
deposited into a mass of tissue (1 Gy = 100 rads). In this document, the 
referenced absorbed dose is that dose inside the patient’s body (i.e., the 
dose that is normally measured with personal dosimeters).
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THE THREE CLASSIC 
ARS SYNDROM ARE:
• Bone marrow syndrome (sometimes referred to as hematopoietic 
syndrome): the full syndrome will usually occur with a dose greater 
than approximately 0.7 Gy (70 rads) although mild symptoms 
may occur as low as 0.3 Gy or 30 rads.4
 ° The survival rate of patients with this syndrome decreases with 
increasing dose. The primary cause of death is the destruction 
of the bone marrow, resulting in infection and hemorrhage.
• Gastrointestinal (GI) syndrome: the full syndrome will usually 
occur with a dose greater than approximately 10 Gy (1000 rads) 
although some symptoms may occur as low as 6 Gy or 600 rads.
 ° Survival is extremely unlikely with this syndrome. Destructive 
and irreparable changes in the GI tract and bone marrow usually 
cause infection, dehydration, and electrolyte imbalance. Death 
usually occurs within 2 weeks.
• Cardiovascular (CV)/ Central Nervous System (CNS) syndrome: 
the full syndrome will usually occur with a dose greater than 
approximately 50 Gy (5000 rads) although some symptoms may 
occur as low as 20 Gy or 2000 rads.
 ° Death occurs within 3 days. Death likely is due to collapse of the 
circulatory system as well as increased pressure in the confining 
cranial vault as the result of increased fl uid content caused by 
edema, vasculitis, and meningitis.
2 The referenced absorbed dose levels in this document are assumed to be 
from beta, gamma, or x radiation. Neutron or proton radiation produces 
many of the health effects described herein at lower absorbed dose levels. 
3 The dose may not be uniform, but a large portion of the body must have 
received more than 0.7 Gy (70 rads).
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THE FOUR STAGES 
OF ARS ARE:
• Prodromal stage (N-V-D stage): The classic symptoms for this 
stage are nausea, vomiting, as well as anorexia and possibly 
diarrhea (depending on dose), which occur from minutes to days 
following exposure. The symptoms may last (episodically) for 
minutes up to several days.
• Latent stage: In this stage, the patient looks and feels generally 
healthy for a few hours or even up to a few weeks.
• Manifest illness stage: In this stage, the symptoms depend on the 
specifi c syndrome (see Table 1) and last from hours up to several 
months.
• Recovery or death: Most patients who do not recover will die 
within several months of exposure. The recovery process lasts 
from several weeks up to two years. These stages are described 
in more detail in Table 1 (refer to the enclosure at the end of this 
document).
These stages are described in further detail in Table 1
CUTANEOUS 
RADIATION SYNDROM (CRS)
The concept of cutaneous radiation syndrome (CRS) was introduced 
in recent years to describe the complex pathological syndrome that 
results from acute radiation exposure to the skin.
ARS usually will be accompanied by some skin damage. It is also 
possible to receive a damaging dose to the skin without symptoms 
of ARS, especially with acute exposures to beta radiation or X-rays. 
Sometimes this occurs when radioactive materials contaminate a 
patient’s skin or clothes.
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When the basal cell layer of the skin is damaged by radiation, 
inflammation, erythema, and dry or moist desquamation can occur. 
Also, hair follicles may be damaged, causing epilation. Within a 
few hours after irradiation, a transient and inconsistent erythema 
(associated with itching) can occur. Then, a latent phase may 
occur and last from a few days up to several weeks, when intense 
reddening, blistering, and ulceration of the irradiated site are visible.
In most cases, healing occurs by regenerative means; however, very 
large skin doses can cause permanent hair loss, damaged sebaceous 
and sweat glands, atrophy, fibrosis, decreased or increased skin 
pigmentation, and ulceration or necrosis of the exposed tissue.
PATIENT 
MANAGEMENT
Triage: If radiation exposure is suspected:
• Secure ABCs (airway, breathing, circulation) and physiologic 
monitoring (blood pressure, blood gases, electrolyte and urine 
output) as appropriate.
• Treat major trauma, burns, and respiratory injury if evident.
• In addition to the blood samples required to address the trauma, 
obtain blood samples for CBC (complete blood count), with 
attention to lymphocyte count, and HLA (human leukocyte 
antigen) typing prior to any initial transfusion and at periodic 
intervals following transfusion.
• Treat contamination as needed.
• If exposure occurred within 8 to 12 hours, repeat CBC, with 
attention to lymphocyte count, 2 or 3 more times (approximately 
every 2 to 3 hours) to assess lymphocyte depletion.
Diagnosis
The diagnosis of ARS can be difficult to make because ARS causes 
no unique disease. Also, depending on the dose, the prodromal 
stage may not occur for hours or days after exposure, or the 
patient may already be in the latent stage by the time they receive 
treatment, in which case the patient may appear and feel well when 
first assessed.
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If a patient received more than 0.05 Gy (5 rads) and three or four 
CBCs are taken within 8 to 12 hours of the exposure, a quick estimate 
of the dose can be made (see Ricks, et. al. for details). If these initial 
blood counts are not taken, the dose can still be estimated by using 
CBC results over the first few days. It would be best to have radiation 
dosimetrists conduct the dose assessment, if possible. 
If a patient is known to have been or suspected of having been 
exposed to a large radiation dose, draw blood for CBC analysis with 
special attention to the lymphocyte count, every 2 to 3 hours for 
the fi rst 8 hours after exposure (and every 4 to 6 hours for the next 
2 days). Observe the patient during this time for symptoms and 
consult with radiation experts before ruling out ARS.
If no radiation exposure is initially suspected, you may consider 
ARS in the differential diagnosis if a history exists of nausea and 
vomiting that is unexplained by other causes. Other indications are 
bleeding, epilation, or white blood count (WBC) and platelet counts 
abnormally low a few days or weeks after unexplained nausea 
and vomiting. Again, consider CBC and chromosome analysis and 
consultation with radiation experts to confirm diagnosis.
Initial Treatment and Diagnostic Evaluation
Treat vomiting  and repeat CBC analysis with special attention to 
the lymphocyte count every 2 to 3 hours for the fi rst 8 to 12 hours 
after exposure (and every 4 to 6 hours for the following 2 or 3 days). 
Sequential changes in absolute lymphocyte counts over time are 
demonstrated below in the Andrews Lymphocyte Nomogram (see 
Figure 1). Precisely record all clinical symptoms, particularly nausea, 
vomiting, diarrhea, and itching, reddening or blistering of the skin. 
Be sure to include time of onset.
5 Collect vomitus in the first few days for later analysis
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Figure 1: Andrews Lymphocyte Nomogram
From Andrews GA,
Auxier JA, Lushbaugh
CC. The Importance
of Dosimetry to the
Medical Management
of Persons Exposed
to High Levels of
Radiation. In Personal
Dosimetry for Radiation
Accidents. Vienna:
International Atomic
Energy Agency; 1965.
Note and record areas of erythema. If possible, take 
color photographs of suspected radiation skin damage. Consider 
tissue, blood typing, and initiating viral prophylaxis. Promptly 
consult with radiation, hematology, and radiotherapy experts about 
dosimetry, prognosis, and treatment options. Call the Radiation 
Emergency Assistance Center/Training Site (REAC/TS) at (865) 
576-3131 (M-F, 8 am to 4:30 pm EST) or (865) 576-1005 (after hours) 
to record the incident in the Radiation Accident Registry System.
After consultation, begin the following treatment (as indicated):
 ° supportive care in a clean environment (if available, the use of a 
burn unit may be quite effective)
 ° prevention and treatment of infections
 ° stimulation of hematopoiesis by use of growth factors
 ° stem cell transfusions or platelet transfusions (if platelet count 
is too low)
 ° psychological support
 ° careful observation for erythema (document locations), hair 
loss, skin injury,  mucositis, parotitis, weight loss, or fever
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 ° confirmation of initial dose estimate using chromosome 
aberration cytogenetic bioassay when possible. Although 
resource intensive, this is the best method of dose assessment 
following acute exposures
 ° consultation with experts in radiation accident management
FOR MORE HELP
Technical assistance can be obtained from the Radiation Emergency 
Assistance Center/Training Site (REAC/TS) at (865) 576-3131 (M-F, 
8 am to 4:30 pm EST) or (865) 576-1005 (after hours), or on their 
web site at www.orau.gov reacts/, and the Medical Radiobiology 
Advisory Team (MRAT) at (301) 295-0316. 
Also, more information can be obtained from the CDC Health Alert 
Network at www.bt.cdc.gov or by calling 
(800) 311-3435.
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ENCLOSED
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SYNDROME DOSE* PRODROMAL STAGE LATENT STAGE MANIFEST ILLNESS STAGE RECOVERY
Hematopoietic
(Bone Marrow)
> 0.7 Gy (> 70 
rads)
(mild symptoms 
may occur as low 
as 0.3 Gy or 30 
rads)
• Symptoms are anorexia, 
nausea and vomiting.
• Onset occurs 1 hour to 2 
days after exposure.
• Stage lasts for minutes to 
days.
• Stem cells in bone 
marrow are dying, 
although patient may 
appear and feel well.
• Stage lasts 1 to 6 weeks.
• Symptoms are anorexia, 
fever, and malaise.
• Drop in all blood cell 
counts occurs for several 
weeks.
• Primary cause of 
death is infection and 
hemorrhage.
• Survival decreases with 
increasing dose.
• Most deaths occur 
within a few months 
after exposure.
• In most cases, bone 
marrow cells will begin 
to repopulate the 
marrow.
• There should be 
full recovery for a 
large percentage of 
individuals from a few 
weeks up to two years 
after exposure.
• death may occur in 
some individuals at 1.2 
Gy (120 rads).
• the LD50/60† is about 
2.5 to 5 Gy (250 to 500 
rads)
Gastrointestinal 
(GI)
> 10 Gy (> 1000 
rads)
(some symptoms 
may occur as low 
as 6 Gy or 600 
rads)
• Symptoms are anorexia, 
severe nausea, vomiting, 
cramps, and diarrhea.
• Onset occurs within 
a few hours after 
exposure.
• Stage lasts about 2 
days.
• Stem cells in bone 
marrow and cells lining 
GI tract are dying, 
although patient may 
appear and feel well.
• Stage lasts less than 1 
week.
• Symptoms are 
malaise, anorexia, 
severe diarrhea, fever, 
dehydration, and 
electrolyte imbalance.
• Death is due to infection, 
dehydration, and 
electrolyte imbalance.
• Death occurs within 2 
weeks of exposure.
• the LD100‡ is about 10 
Gy (1000 rads)
Cardiovascular 
(CV)/ Central 
Nervous System 
(CNS)
> 50 Gy (5000 
rads)
(some symptoms 
may occur as low 
as 20 Gy or 2000 
rads)
• Symptoms are extreme 
nervousness and 
confusion; severe 
nausea, vomiting, and 
watery diarrhea; loss 
of consciousness; and 
burning sensations of 
the skin.
• Onset occurs within 
minutes of exposure.
• Stage lasts for minutes 
to hours.
• Patient may return to 
partial functionality.
• Stage may last for 
hours but often is less.
• Symptoms are return 
of watery diarrhea, 
convulsions, and coma.
• Onset occurs 5 to 6 
hours after exposure.
• Death occurs within 3 
days of exposure.
• No recovery is 
expected.
* The absorbed doses quoted here are “gamma equivalent” values. Neutrons or protons generally produce the same effects as gamma, beta, or X-rays but at lower doses. If the 
patient has been exposed to neutrons or protons, consult radiation experts on how to interpret the dose.
† The LD50/60 is the dose necessary to kill 50% of the exposed population in 60 days.
‡ The LD100 is the dose necessary to kill 100% of the exposed population
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Acute Radiation 
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